Equibles does not estimate personal net worth.
Get an email with a short summary when NEUROONE MEDICAL TECHNOLOGIES Corp publishes a filing, an earnings call transcript or a press release.
Get NMTC alertsRon McClurg is recorded as CFO at NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC). The proxy statement of NEUROONE MEDICAL TECHNOLOGIES Corp reports total compensation of $523,822 for Ron McClurg in fiscal 2025, including a base salary of $324,996. Disclosed compensation is on record for 6 fiscal years. Ron McClurg has spoken on 15 earnings calls across 1 company, most recently for NEUROONE MEDICAL TECHNOLOGIES Corp on May 12, 2026. NEUROONE MEDICAL TECHNOLOGIES Corp is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at NEUROONE MEDICAL TECHNOLOGIES Corp includes Dave Rosa (CEO and Board Member), David Rosa (CEO and Board Member), Paul Buckman (Chairman) and 7 others.
“Product revenue was $2.4 million in the second quarter of fiscal 2026, a 72% increase compared to product revenue of $1.4 million in the second quarter of fiscal 2025.”
“Product revenue increased slightly to $1.4 million in the second quarter of fiscal 2025 compared to product revenue of $1.4 million in the second quarter of fiscal 2024.”
“Product revenue was $3.3 million in the first quarter of fiscal 2025, an increase of 235% compared to our product revenue of $1 million in the first quarter of fiscal 2024.”
“Product revenue was $1.3 million in the fourth quarter of fiscal 2024, down from $1.7 million in the same quarter of the previous year. The decline in product revenue for this quarter was attributed to the cancellation of a Zimmer Biomet purchase order as we transitioned our manufacturing to the new OneRF product line.”
“Product revenue was $1.377 million in the second quarter of fiscal '24 compared to product revenue of only $466,000 in the second quarter of fiscal 2023. For the first six months of fiscal '24, product revenue was $2.355 million compared to $581,000 for the same period of fiscal 2023.”
Medical Devices · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | Chief Financial Officer | $324,996 | $523,822 |
| 2024 | NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | Chief Financial Officer | $316,764 | $598,553 |
| 2023 | NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | Chief Financial Officer | $307,538 | $390,157 |
| 2022 | NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | Chief Financial Officer | $286,719 | $375,563 |
| 2021 | NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | Chief Financial Officer | $187,500 | $522,529 |
| 2020 | NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | Chief Financial Officer | — | — |
